Literature DB >> 30120627

To stop or not to stop: a value of information view.

Uwe Siebert1,2,3,4, Lára R Hallsson5,6.   

Abstract

Mesh:

Year:  2018        PMID: 30120627     DOI: 10.1007/s10654-018-0432-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  14 in total

Review 1.  Futility approaches to interim monitoring by data monitoring committees.

Authors:  David L Demets
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

2.  Assessment of futility in clinical trials.

Authors:  Steven Snapinn; Mon-Gy Chen; Qi Jiang; Tony Koutsoukos
Journal:  Pharm Stat       Date:  2006 Oct-Dec       Impact factor: 1.894

Review 3.  When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.

Authors:  Uwe Siebert; Ursula Rochau; Karl Claxton
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2013-11-12

4.  Conditional power as an aid in making interim decisions in observational studies.

Authors:  Alexander Muir Walker
Journal:  Eur J Epidemiol       Date:  2018-05-28       Impact factor: 8.082

5.  The Fate of FDA Postapproval Studies.

Authors:  Steven Woloshin; Lisa M Schwartz; Brian White; Thomas J Moore
Journal:  N Engl J Med       Date:  2017-09-21       Impact factor: 91.245

6.  Per-Protocol Analyses of Pragmatic Trials.

Authors:  Miguel A Hernán; James M Robins
Journal:  N Engl J Med       Date:  2017-10-05       Impact factor: 91.245

7.  An aid to data monitoring in long-term clinical trials.

Authors:  M Halperin; K K Lan; J H Ware; N J Johnson; D L DeMets
Journal:  Control Clin Trials       Date:  1982-12

8.  Expected value of sample information calculations in medical decision modeling.

Authors:  A E Ades; G Lu; K Claxton
Journal:  Med Decis Making       Date:  2004 Mar-Apr       Impact factor: 2.583

9.  Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies.

Authors:  M Jitlal; I Khan; S M Lee; A Hackshaw
Journal:  Br J Cancer       Date:  2012-08-09       Impact factor: 7.640

10.  Improved adherence adjustment in the Coronary Drug Project.

Authors:  Eleanor J Murray; Miguel A Hernán
Journal:  Trials       Date:  2018-03-05       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.